DAMASSI, ALESSANDRA

DAMASSI, ALESSANDRA  

100007 - Dipartimento di Medicina interna e specialità mediche  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autore(i) File
1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study 1-gen-2022 Rebuzzi, S. E.; Rescigno, P.; Signori, A.; Brunelli, M.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Milella, M.; Vignani, F.; Cavo, A.; Basso, U.; Catalano, F.; Murianni, V.; Cremante, M.; Damassi, A.; Llaja Obispo, M. A.; Banna, G. L.; Buti, S.; Fornarini, G.
597P Endometrial carcinoma and mismatch repair deficiency: Clinical association and universal screening for Lynch syndrome 1-gen-2022 Puglisi, S.; Ponzano, M.; Perachino, M.; Pirrone, C.; Damassi, A.; Bregni, G.; Puccini, A.; Grassi, M.; Trevisan, L.; Gismondi, V.; Dono, M.; Lastraioli, S.; Fedele, P.; Cremante, M.; Gandini, A.; Giannelli, F.; Mammoliti, S.; Vellone, V. G.; Sciallero, M. S.; Iaia, M. L.
802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study 1-gen-2020 Brunelli, M; Buti, S.; Rebuzzi, S. E.; Milella, M.; Vellone, V.; Bersanelli, M.; Maruzzo, M.; Basso, U.; Signori, A.; Martelli, V.; Catalano, F.; Damassi, A.; Murianni, V.; Merler, S.; Casartelli, C.; Fornarini, G.
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients 1-gen-2020 Arecco, L.; Perachino, M.; Damassi, A.; Latocca, M. M.; Soldato, D.; Vallome, G.; Parisi, F.; Razeti, M. G.; Solinas, C.; Tagliamento, M.; Spinaci, S.; Massarotti, C.; Lambertini, M.
Feasibility of multiple immunoexpression assay for immune tumor micrornvironment (I-TME) on matched metastatic and primary renal cell carcinoma (RCC) for patient prognostication and predictiveness to immunotherapy (preliminary analyses of the Meet URO 18 study). 1-gen-2021 Brunelli, Matteo; Rebuzzi, SARA ELENA; Vellone, VALERIO GAETANO; Sbaraglia, Marta; Gaggero, Gabriele; Fassan, Matteo; Maruzzo, Marco; Basso, Umberto; Bersanelli, Melissa; Damassi, Alessandra; Martelli, Valentino; Catalano, Fabio; Pierantoni, Francesco; Casartelli, Chiara; Merler, Sara; Businello, Gianluca; Milella, Michele; Buti, Sebastiano; Fornarini, Giuseppe
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 1-gen-2020 Arecco, Luca; Blondeaux, Eva; Damassi, Alessandra; Fregatti, Piero; Lambertini, Matteo
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 1-gen-2020 Arecco, Luca; Blondeaux, Eva; Damassi, Alessandra; Fregatti, Piero; Lambertini, Matteo
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment 1-gen-2020 Arecco, Luca; Blondeaux, Eva; Damassi, Alessandra; Fregatti, Piero; Lambertini, Matteo
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 1-gen-2020 Bauckneht, M.; Rebuzzi, S. E.; Signori, A.; Donegani, M. I.; Murianni, V.; Miceli, A.; Borea, R.; Raffa, S.; Damassi, A.; Ponzano, M.; Catalano, F.; Martelli, V.; Marini, C.; Boccardo, F.; Morbelli, S.; Sambuceti, G.; Fornarini, G.